Julie K. Staley

7.0k total citations · 1 hit paper
85 papers, 5.5k citations indexed

About

Julie K. Staley is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Julie K. Staley has authored 85 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Cellular and Molecular Neuroscience, 62 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Julie K. Staley's work include Receptor Mechanisms and Signaling (40 papers), Neurotransmitter Receptor Influence on Behavior (39 papers) and Neuroscience and Neuropharmacology Research (32 papers). Julie K. Staley is often cited by papers focused on Receptor Mechanisms and Signaling (40 papers), Neurotransmitter Receptor Influence on Behavior (39 papers) and Neuroscience and Neuropharmacology Research (32 papers). Julie K. Staley collaborates with scholars based in United States, Puerto Rico and Canada. Julie K. Staley's co-authors include Deborah C. Mash, Kelly Cosgrove, Carolyn M. Mazure, John Seibyl, Robert B. Innis, Christopher H. van Dyck, Robert T. Malison, Ronald M. Baldwin, Gilles Tamagnan and Sami S. Zoghbi and has published in prestigious journals such as Journal of Neuroscience, NeuroImage and American Journal of Psychiatry.

In The Last Decade

Julie K. Staley

85 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolving Knowledge of Sex Differences in Brain Structure, Function, and Chemistry

2007 713 citations Kelly Cosgrove, Julie K. Staley et al. Biological Psychiatry profile →

Peers

Countries citing papers authored by Julie K. Staley

Since Specialization

Citations

This map shows the geographic impact of Julie K. Staley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie K. Staley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie K. Staley more than expected).

Fields of papers citing papers by Julie K. Staley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie K. Staley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie K. Staley. The network helps show where Julie K. Staley may publish in the future.

Co-authorship network of co-authors of Julie K. Staley

This figure shows the co-authorship network connecting the top 25 collaborators of Julie K. Staley. A scholar is included among the top collaborators of Julie K. Staley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie K. Staley. Julie K. Staley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing the sensitivity of [¹¹C]p943, a novel 5‐HT_IB radioligand, to endogenous serotonin release 2011 ·Synapse ·Kelly Cosgrove, Tracy Kloczynski, Nabeel Nabulsi, David Weinzimmer, Shu-fei Lin, Julie K. Staley, Zubin Bhagwagar, Richard E. Carson	16
2	SPECT imaging with the serotonin transporter radiotracer [123I]p ZIENT in nonhuman primate brain 2010 ·Nuclear Medicine and Biology ·Kelly Cosgrove, Julie K. Staley, Ronald M. Baldwin, Frédéric Y. Bois, Christophe Plisson, Mohammed S. Al‐Tikriti, John Seibyl, Mark M. Goodman, Gilles Tamagnan	6
3	Decreased Beta₂‐nicotinic acetylcholine receptor availability after chronic ethanol exposure in nonhuman primates 2010 ·Synapse* ·Kelly Cosgrove, Tracy Kloczynski, Frédéric Y. Bois, Brian Pittman, Gilles Tamagnan, John Seibyl, John H. Krystal, Julie K. Staley	11
4	¹²³I-5-IA-85380 SPECT Imaging of Nicotinic Receptors in Alzheimer Disease and Mild Cognitive Impairment 2009 ·Journal of Nuclear Medicine ·Effie Mitsis, (unknown), Frédéric Y. Bois, Gilles Tamagnan, Martha G. MacAvoy, John Seibyl, Julie K. Staley, Christopher H. van Dyck	26
5	β2 Nicotinic acetylcholine receptor availability in post-traumatic stress disorder 2008 ·The International Journal of Neuropsychopharmacology ·(unknown), Julie K. Staley, (unknown), Frédéric Y. Bois, Theresa Young, Shannan Henry, Gilles Tamagnan, John Seibyl, John H. Krystal, Alexander Neumeister	17
6	Smoking Comorbidity in Alcoholism: Neurobiological and Neurocognitive Consequences 2006 ·Alcoholism Clinical and Experimental Research ·Dieter J. Meyerhoff, Yousef Tizabi, Julie K. Staley, Timothy C. Durazzo, Jennifer M. Glass, Sara Jo Nixon	80
7	Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER 2006 ·Bioorganic & Medicinal Chemistry Letters ·Gilles Tamagnan, (unknown), David Alagille, Julie K. Staley, Colin N. Haile, Andrei O. Koren, Michelle Early, Ronald M. Baldwin, Frank I. Tarazi, Ross J. Baldessarini, Nachwa Jarkas, Mark M. Goodman, John Seibyl	19
8	Sex Differences in Diencephalon Serotonin Transporter Availability in Major Depression 2005 ·Biological Psychiatry ·Julie K. Staley, Gerard Sanacora, Gilles Tamagnan, Paul K. Maciejewski, Robert T. Malison, Robert Berman, Meena Vythilingam, Akira Kugaya, Ronald M. Baldwin, John Seibyl, Dennis S. Charney, Robert B. Innis	80
9	Cortical γ-Aminobutyric Acid Type A–Benzodiazepine Receptors in Recovery From Alcohol Dependence 2005 ·Archives of General Psychiatry ·Julie K. Staley, Christopher Gottschalk, Ismene L. Petrakis, Ralitza Gueorguieva, Stephanie S. O’Malley, Ronald M. Baldwin, Peter Jatlow, Nicolaas Paul L.G. Verhoeff, Edward Perry, David Weinzimmer, Erin Frohlich, (unknown), Christopher H. van Dyck, John Seibyl, Robert B. Innis, John H. Krystal	35
10	Unaltered Dopamine Transporter Availability in Adult Attention Deficit Hyperactivity Disorder 2002 ·American Journal of Psychiatry ·Christopher H. van Dyck, Donald M. Quinlan, (unknown), Julie K. Staley, Robert T. Malison, Ronald M. Baldwin, John Seibyl, Robert B. Innis	98
11	Equilibrium modeling of 5-ht2a receptors with [18f]deuteroaltanserin and pet: feasibility of a constant infusion paradigm 2000 ·Nuclear Medicine and Biology ·Christopher H van Dyck, Jair C. Soares, (unknown), Julie K. Staley, Ronald M. Baldwin, (unknown), Xing Fu, Pradeep Garg, John Seibyl, Dennis S. Charney, Robert B. Innis	16
12	Kinetic and equilibrium analyses of [123I]epidepride binding to striatal and extrastriatal dopamine D2 receptors 1999 ·Synapse ·Masahiro Fujita, John Seibyl, Nicholaas Paul L.G. Verhoeff, Masanori Ichise, Ronald M. Baldwin, Sami S. Zoghbi, Cyrill Burger, Julie K. Staley, Nallakkandi Rajeevan, Dennis S. Charney, Robert B. Innis	44
13	Vesicular monoamine transporter immunoreactivity is reduced in Parkinsons diseased striatum 1996 ·The Society for Neuroscience Abstracts ·(unknown), (unknown), (unknown), Julie K. Staley, Deborah C. Mash, David B. Rye, Allan I. Levey	1
14	The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain 1995 ·Neuroreport ·Michael H. Baumann, Deborah C. Mash, Julie K. Staley	43
15	Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex 1995 ·Neuroscience Letters ·Deborah C. Mash, Julie K. Staley, John Pablo, Alice M. Holohean, J.C. Hackman, Robert A. Davidoff	68
16	[3H]-(+)-pentazocine binding to sigma recognition sites in human cerebellum 1994 ·Life Sciences ·Cyrus P. Zabetian, Julie K. Staley, Donna D. Flynn, Deborah C. Mash	17
17	[Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo. 1991 ·PubMed ·Soliman A. Mahmoud, Julie K. Staley, John E. Taylor, Arthur E. Bogdén, J P Moreau, D.H. Coy, Ingalill Avis, Frank Cuttitta, James L. Mulshine, Terry W. Moody	140
18	[Des-Met14]Bombesin analogues function as small cell lung cancer bombesin receptor antagonists 1991 ·Peptides ·Julie K. Staley, D.H. Coy, John E. Taylor, (unknown), Terry W. Moody	24
19	CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells 1990 ·Peptides ·Julie K. Staley, (unknown), Terry W. Moody	26
20	Human glioblastoma cell lines have neuropeptide receptors for bombesin/gastrin-releasing peptide. 1989 ·PubMed ·Terry W. Moody, Soliman A. Mahmoud, Julie K. Staley, Luigi Naldini, Daniela María Cirillo, Victoria South, Stefan Felder, Richard Kris	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact